Status:
UNKNOWN
Study of Optimal Treatment Plan in Hypertensives With Anti-AT1-Receptor Autoantibody
Lead Sponsor:
Huazhong University of Science and Technology
Conditions:
Hypertension
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
The autoantibodies against AT1 receptor (ATR-AA), behaving like an agonist were detected in patients with hypertension. ATR-AA which can blocked by ARB may play a role in the pathogenesis of hypertens...
Eligibility Criteria
Inclusion
- Hypertension (2 grade)
Exclusion
- Secondary hypertension
- Known sensitivity or intolerance to an angiotensin II receptor antagonist or ACE inhibitor
- Pregnancy
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
December 1 2006
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT00360763
End Date
December 1 2006
Last Update
August 7 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Cardiology, Wuhan Union Hospital
Wuhan, Hubei, China, 430022